img

Global Polypeptide Drug Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Polypeptide Drug Market Insights, Forecast to 2034

Polypeptide antibiotic. Polypeptide antibiotics are a chemically diverse class of anti-infective and antitumor antibiotics containing non-protein polypeptide chains. Examples of this class include actinomycin, bacitracin, colistin, and polymyxin B. Actinomycin-D has found use in cancer chemotherapy.
Global Polypeptide Drug market is expected to reach to US$ 715 million in 2024, with a positive growth of %, compared with US$ 689 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Polypeptide Drug industry is evaluated to reach US$ 1037.4 million in 2029. The CAGR will be 6.4% during 2024 to 2029.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Polypeptide Drug market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Polypeptide Drug market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Novartis
Merck Serono
Ferring Pharmaceuticals
Ipsen PHarma Biotech
Lilly
Asahi Kasei
AstraZeneca
SciClone Pharmaceuticals
Takeda
Roche
Sanofi
Segment by Type
Injection
Nasal Administration
Lung Administration
Oral Administration
Transdermal Administration

Segment by Application


Immunity Regulating Medicine (Allergy Infection and Immune)
Digestive System Drugs (Gastrointestinal Type)
Bone and Connective Tissue Types (Thyroid hormones Drug)
Gynecologic or Obstetric Drug
Tumor Drug
Urinary System Drug
Metabolic Drug (Insulin and Other Hypoglycemic Agents)

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Polypeptide Drug plant distribution, commercial date of Polypeptide Drug, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Polypeptide Drug introduction, etc. Polypeptide Drug Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Polypeptide Drug
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Polypeptide Drug Product Introduction
1.2 Market by Type
1.2.1 Global Polypeptide Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Injection
1.2.3 Nasal Administration
1.2.4 Lung Administration
1.2.5 Oral Administration
1.2.6 Transdermal Administration
1.3 Market by Application
1.3.1 Global Polypeptide Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Immunity Regulating Medicine (Allergy Infection and Immune)
1.3.3 Digestive System Drugs (Gastrointestinal Type)
1.3.4 Bone and Connective Tissue Types (Thyroid hormones Drug)
1.3.5 Gynecologic or Obstetric Drug
1.3.6 Tumor Drug
1.3.7 Urinary System Drug
1.3.8 Metabolic Drug (Insulin and Other Hypoglycemic Agents)
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Polypeptide Drug Sales Estimates and Forecasts 2018-2029
2.2 Global Polypeptide Drug Revenue by Region
2.2.1 Global Polypeptide Drug Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Polypeptide Drug Revenue by Region (2018-2024)
2.2.3 Global Polypeptide Drug Revenue by Region (2024-2029)
2.2.4 Global Polypeptide Drug Revenue Market Share by Region (2018-2029)
2.3 Global Polypeptide Drug Sales Estimates and Forecasts 2018-2029
2.4 Global Polypeptide Drug Sales by Region
2.4.1 Global Polypeptide Drug Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Polypeptide Drug Sales by Region (2018-2024)
2.4.3 Global Polypeptide Drug Sales by Region (2024-2029)
2.4.4 Global Polypeptide Drug Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Polypeptide Drug Sales by Manufacturers
3.1.1 Global Polypeptide Drug Sales by Manufacturers (2018-2024)
3.1.2 Global Polypeptide Drug Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Polypeptide Drug in 2022
3.2 Global Polypeptide Drug Revenue by Manufacturers
3.2.1 Global Polypeptide Drug Revenue by Manufacturers (2018-2024)
3.2.2 Global Polypeptide Drug Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Polypeptide Drug Revenue in 2022
3.3 Global Key Players of Polypeptide Drug, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Polypeptide Drug Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Polypeptide Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Polypeptide Drug, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Polypeptide Drug, Product Offered and Application
3.8 Global Key Manufacturers of Polypeptide Drug, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Polypeptide Drug Sales by Type
4.1.1 Global Polypeptide Drug Historical Sales by Type (2018-2024)
4.1.2 Global Polypeptide Drug Forecasted Sales by Type (2024-2029)
4.1.3 Global Polypeptide Drug Sales Market Share by Type (2018-2029)
4.2 Global Polypeptide Drug Revenue by Type
4.2.1 Global Polypeptide Drug Historical Revenue by Type (2018-2024)
4.2.2 Global Polypeptide Drug Forecasted Revenue by Type (2024-2029)
4.2.3 Global Polypeptide Drug Revenue Market Share by Type (2018-2029)
4.3 Global Polypeptide Drug Price by Type
4.3.1 Global Polypeptide Drug Price by Type (2018-2024)
4.3.2 Global Polypeptide Drug Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Polypeptide Drug Sales by Application
5.1.1 Global Polypeptide Drug Historical Sales by Application (2018-2024)
5.1.2 Global Polypeptide Drug Forecasted Sales by Application (2024-2029)
5.1.3 Global Polypeptide Drug Sales Market Share by Application (2018-2029)
5.2 Global Polypeptide Drug Revenue by Application
5.2.1 Global Polypeptide Drug Historical Revenue by Application (2018-2024)
5.2.2 Global Polypeptide Drug Forecasted Revenue by Application (2024-2029)
5.2.3 Global Polypeptide Drug Revenue Market Share by Application (2018-2029)
5.3 Global Polypeptide Drug Price by Application
5.3.1 Global Polypeptide Drug Price by Application (2018-2024)
5.3.2 Global Polypeptide Drug Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Polypeptide Drug Market Size by Type
6.1.1 US & Canada Polypeptide Drug Sales by Type (2018-2029)
6.1.2 US & Canada Polypeptide Drug Revenue by Type (2018-2029)
6.2 US & Canada Polypeptide Drug Market Size by Application
6.2.1 US & Canada Polypeptide Drug Sales by Application (2018-2029)
6.2.2 US & Canada Polypeptide Drug Revenue by Application (2018-2029)
6.3 US & Canada Polypeptide Drug Market Size by Country
6.3.1 US & Canada Polypeptide Drug Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Polypeptide Drug Sales by Country (2018-2029)
6.3.3 US & Canada Polypeptide Drug Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Polypeptide Drug Market Size by Type
7.1.1 Europe Polypeptide Drug Sales by Type (2018-2029)
7.1.2 Europe Polypeptide Drug Revenue by Type (2018-2029)
7.2 Europe Polypeptide Drug Market Size by Application
7.2.1 Europe Polypeptide Drug Sales by Application (2018-2029)
7.2.2 Europe Polypeptide Drug Revenue by Application (2018-2029)
7.3 Europe Polypeptide Drug Market Size by Country
7.3.1 Europe Polypeptide Drug Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Polypeptide Drug Sales by Country (2018-2029)
7.3.3 Europe Polypeptide Drug Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Polypeptide Drug Market Size
8.1.1 China Polypeptide Drug Sales (2018-2029)
8.1.2 China Polypeptide Drug Revenue (2018-2029)
8.2 China Polypeptide Drug Market Size by Application
8.2.1 China Polypeptide Drug Sales by Application (2018-2029)
8.2.2 China Polypeptide Drug Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Polypeptide Drug Market Size by Type
9.1.1 Asia Polypeptide Drug Sales by Type (2018-2029)
9.1.2 Asia Polypeptide Drug Revenue by Type (2018-2029)
9.2 Asia Polypeptide Drug Market Size by Application
9.2.1 Asia Polypeptide Drug Sales by Application (2018-2029)
9.2.2 Asia Polypeptide Drug Revenue by Application (2018-2029)
9.3 Asia Polypeptide Drug Sales by Region
9.3.1 Asia Polypeptide Drug Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Polypeptide Drug Revenue by Region (2018-2029)
9.3.3 Asia Polypeptide Drug Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Polypeptide Drug Market Size by Type
10.1.1 Middle East, Africa and Latin America Polypeptide Drug Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Polypeptide Drug Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Polypeptide Drug Market Size by Application
10.2.1 Middle East, Africa and Latin America Polypeptide Drug Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Polypeptide Drug Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Polypeptide Drug Sales by Country
10.3.1 Middle East, Africa and Latin America Polypeptide Drug Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Polypeptide Drug Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Polypeptide Drug Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Novartis
11.1.1 Novartis Company Information
11.1.2 Novartis Overview
11.1.3 Novartis Polypeptide Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Novartis Polypeptide Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Novartis Recent Developments
11.2 Merck Serono
11.2.1 Merck Serono Company Information
11.2.2 Merck Serono Overview
11.2.3 Merck Serono Polypeptide Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Merck Serono Polypeptide Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Merck Serono Recent Developments
11.3 Ferring Pharmaceuticals
11.3.1 Ferring Pharmaceuticals Company Information
11.3.2 Ferring Pharmaceuticals Overview
11.3.3 Ferring Pharmaceuticals Polypeptide Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Ferring Pharmaceuticals Polypeptide Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Ferring Pharmaceuticals Recent Developments
11.4 Ipsen PHarma Biotech
11.4.1 Ipsen PHarma Biotech Company Information
11.4.2 Ipsen PHarma Biotech Overview
11.4.3 Ipsen PHarma Biotech Polypeptide Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Ipsen PHarma Biotech Polypeptide Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Ipsen PHarma Biotech Recent Developments
11.5 Lilly
11.5.1 Lilly Company Information
11.5.2 Lilly Overview
11.5.3 Lilly Polypeptide Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Lilly Polypeptide Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Lilly Recent Developments
11.6 Asahi Kasei
11.6.1 Asahi Kasei Company Information
11.6.2 Asahi Kasei Overview
11.6.3 Asahi Kasei Polypeptide Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Asahi Kasei Polypeptide Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Asahi Kasei Recent Developments
11.7 AstraZeneca
11.7.1 AstraZeneca Company Information
11.7.2 AstraZeneca Overview
11.7.3 AstraZeneca Polypeptide Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 AstraZeneca Polypeptide Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 AstraZeneca Recent Developments
11.8 SciClone Pharmaceuticals
11.8.1 SciClone Pharmaceuticals Company Information
11.8.2 SciClone Pharmaceuticals Overview
11.8.3 SciClone Pharmaceuticals Polypeptide Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 SciClone Pharmaceuticals Polypeptide Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 SciClone Pharmaceuticals Recent Developments
11.9 Takeda
11.9.1 Takeda Company Information
11.9.2 Takeda Overview
11.9.3 Takeda Polypeptide Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Takeda Polypeptide Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Takeda Recent Developments
11.10 Roche
11.10.1 Roche Company Information
11.10.2 Roche Overview
11.10.3 Roche Polypeptide Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 Roche Polypeptide Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Roche Recent Developments
11.11 Sanofi
11.11.1 Sanofi Company Information
11.11.2 Sanofi Overview
11.11.3 Sanofi Polypeptide Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 Sanofi Polypeptide Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Sanofi Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Polypeptide Drug Industry Chain Analysis
12.2 Polypeptide Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Polypeptide Drug Production Mode & Process
12.4 Polypeptide Drug Sales and Marketing
12.4.1 Polypeptide Drug Sales Channels
12.4.2 Polypeptide Drug Distributors
12.5 Polypeptide Drug Customers
13 Market Dynamics
13.1 Polypeptide Drug Industry Trends
13.2 Polypeptide Drug Market Drivers
13.3 Polypeptide Drug Market Challenges
13.4 Polypeptide Drug Market Restraints
14 Key Findings in The Global Polypeptide Drug Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Polypeptide Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Injection
Table 3. Major Manufacturers of Nasal Administration
Table 4. Major Manufacturers of Lung Administration
Table 5. Major Manufacturers of Oral Administration
Table 6. Major Manufacturers of Transdermal Administration
Table 7. Global Polypeptide Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 8. Global Polypeptide Drug Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 9. Global Polypeptide Drug Revenue by Region (2018-2024) & (US$ Million)
Table 10. Global Polypeptide Drug Revenue by Region (2024-2029) & (US$ Million)
Table 11. Global Polypeptide Drug Revenue Market Share by Region (2018-2024)
Table 12. Global Polypeptide Drug Revenue Market Share by Region (2024-2029)
Table 13. Global Polypeptide Drug Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 14. Global Polypeptide Drug Sales by Region (2018-2024) & (MT)
Table 15. Global Polypeptide Drug Sales by Region (2024-2029) & (MT)
Table 16. Global Polypeptide Drug Sales Market Share by Region (2018-2024)
Table 17. Global Polypeptide Drug Sales Market Share by Region (2024-2029)
Table 18. Global Polypeptide Drug Sales by Manufacturers (2018-2024) & (MT)
Table 19. Global Polypeptide Drug Sales Share by Manufacturers (2018-2024)
Table 20. Global Polypeptide Drug Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 21. Global Polypeptide Drug Revenue Share by Manufacturers (2018-2024)
Table 22. Global Key Players of Polypeptide Drug, Industry Ranking, 2021 VS 2022 VS 2024
Table 23. Polypeptide Drug Price by Manufacturers 2018-2024 (USD/MT)
Table 24. Global Polypeptide Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 25. Global Polypeptide Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Polypeptide Drug as of 2022)
Table 26. Global Key Manufacturers of Polypeptide Drug, Manufacturing Base Distribution and Headquarters
Table 27. Global Key Manufacturers of Polypeptide Drug, Product Offered and Application
Table 28. Global Key Manufacturers of Polypeptide Drug, Date of Enter into This Industry
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Polypeptide Drug Sales by Type (2018-2024) & (MT)
Table 31. Global Polypeptide Drug Sales by Type (2024-2029) & (MT)
Table 32. Global Polypeptide Drug Sales Share by Type (2018-2024)
Table 33. Global Polypeptide Drug Sales Share by Type (2024-2029)
Table 34. Global Polypeptide Drug Revenue by Type (2018-2024) & (US$ Million)
Table 35. Global Polypeptide Drug Revenue by Type (2024-2029) & (US$ Million)
Table 36. Global Polypeptide Drug Revenue Share by Type (2018-2024)
Table 37. Global Polypeptide Drug Revenue Share by Type (2024-2029)
Table 38. Polypeptide Drug Price by Type (2018-2024) & (USD/MT)
Table 39. Global Polypeptide Drug Price Forecast by Type (2024-2029) & (USD/MT)
Table 40. Global Polypeptide Drug Sales by Application (2018-2024) & (MT)
Table 41. Global Polypeptide Drug Sales by Application (2024-2029) & (MT)
Table 42. Global Polypeptide Drug Sales Share by Application (2018-2024)
Table 43. Global Polypeptide Drug Sales Share by Application (2024-2029)
Table 44. Global Polypeptide Drug Revenue by Application (2018-2024) & (US$ Million)
Table 45. Global Polypeptide Drug Revenue by Application (2024-2029) & (US$ Million)
Table 46. Global Polypeptide Drug Revenue Share by Application (2018-2024)
Table 47. Global Polypeptide Drug Revenue Share by Application (2024-2029)
Table 48. Polypeptide Drug Price by Application (2018-2024) & (USD/MT)
Table 49. Global Polypeptide Drug Price Forecast by Application (2024-2029) & (USD/MT)
Table 50. US & Canada Polypeptide Drug Sales by Type (2018-2024) & (MT)
Table 51. US & Canada Polypeptide Drug Sales by Type (2024-2029) & (MT)
Table 52. US & Canada Polypeptide Drug Revenue by Type (2018-2024) & (US$ Million)
Table 53. US & Canada Polypeptide Drug Revenue by Type (2024-2029) & (US$ Million)
Table 54. US & Canada Polypeptide Drug Sales by Application (2018-2024) & (MT)
Table 55. US & Canada Polypeptide Drug Sales by Application (2024-2029) & (MT)
Table 56. US & Canada Polypeptide Drug Revenue by Application (2018-2024) & (US$ Million)
Table 57. US & Canada Polypeptide Drug Revenue by Application (2024-2029) & (US$ Million)
Table 58. US & Canada Polypeptide Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 59. US & Canada Polypeptide Drug Revenue by Country (2018-2024) & (US$ Million)
Table 60. US & Canada Polypeptide Drug Revenue by Country (2024-2029) & (US$ Million)
Table 61. US & Canada Polypeptide Drug Sales by Country (2018-2024) & (MT)
Table 62. US & Canada Polypeptide Drug Sales by Country (2024-2029) & (MT)
Table 63. Europe Polypeptide Drug Sales by Type (2018-2024) & (MT)
Table 64. Europe Polypeptide Drug Sales by Type (2024-2029) & (MT)
Table 65. Europe Polypeptide Drug Revenue by Type (2018-2024) & (US$ Million)
Table 66. Europe Polypeptide Drug Revenue by Type (2024-2029) & (US$ Million)
Table 67. Europe Polypeptide Drug Sales by Application (2018-2024) & (MT)
Table 68. Europe Polypeptide Drug Sales by Application (2024-2029) & (MT)
Table 69. Europe Polypeptide Drug Revenue by Application (2018-2024) & (US$ Million)
Table 70. Europe Polypeptide Drug Revenue by Application (2024-2029) & (US$ Million)
Table 71. Europe Polypeptide Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 72. Europe Polypeptide Drug Revenue by Country (2018-2024) & (US$ Million)
Table 73. Europe Polypeptide Drug Revenue by Country (2024-2029) & (US$ Million)
Table 74. Europe Polypeptide Drug Sales by Country (2018-2024) & (MT)
Table 75. Europe Polypeptide Drug Sales by Country (2024-2029) & (MT)
Table 76. China Polypeptide Drug Sales by Type (2018-2024) & (MT)
Table 77. China Polypeptide Drug Sales by Type (2024-2029) & (MT)
Table 78. China Polypeptide Drug Revenue by Type (2018-2024) & (US$ Million)
Table 79. China Polypeptide Drug Revenue by Type (2024-2029) & (US$ Million)
Table 80. China Polypeptide Drug Sales by Application (2018-2024) & (MT)
Table 81. China Polypeptide Drug Sales by Application (2024-2029) & (MT)
Table 82. China Polypeptide Drug Revenue by Application (2018-2024) & (US$ Million)
Table 83. China Polypeptide Drug Revenue by Application (2024-2029) & (US$ Million)
Table 84. Asia Polypeptide Drug Sales by Type (2018-2024) & (MT)
Table 85. Asia Polypeptide Drug Sales by Type (2024-2029) & (MT)
Table 86. Asia Polypeptide Drug Revenue by Type (2018-2024) & (US$ Million)
Table 87. Asia Polypeptide Drug Revenue by Type (2024-2029) & (US$ Million)
Table 88. Asia Polypeptide Drug Sales by Application (2018-2024) & (MT)
Table 89. Asia Polypeptide Drug Sales by Application (2024-2029) & (MT)
Table 90. Asia Polypeptide Drug Revenue by Application (2018-2024) & (US$ Million)
Table 91. Asia Polypeptide Drug Revenue by Application (2024-2029) & (US$ Million)
Table 92. Asia Polypeptide Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 93. Asia Polypeptide Drug Revenue by Region (2018-2024) & (US$ Million)
Table 94. Asia Polypeptide Drug Revenue by Region (2024-2029) & (US$ Million)
Table 95. Asia Polypeptide Drug Sales by Region (2018-2024) & (MT)
Table 96. Asia Polypeptide Drug Sales by Region (2024-2029) & (MT)
Table 97. Middle East, Africa and Latin America Polypeptide Drug Sales by Type (2018-2024) & (MT)
Table 98. Middle East, Africa and Latin America Polypeptide Drug Sales by Type (2024-2029) & (MT)
Table 99. Middle East, Africa and Latin America Polypeptide Drug Revenue by Type (2018-2024) & (US$ Million)
Table 100. Middle East, Africa and Latin America Polypeptide Drug Revenue by Type (2024-2029) & (US$ Million)
Table 101. Middle East, Africa and Latin America Polypeptide Drug Sales by Application (2018-2024) & (MT)
Table 102. Middle East, Africa and Latin America Polypeptide Drug Sales by Application (2024-2029) & (MT)
Table 103. Middle East, Africa and Latin America Polypeptide Drug Revenue by Application (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Polypeptide Drug Revenue by Application (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Polypeptide Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 106. Middle East, Africa and Latin America Polypeptide Drug Revenue by Country (2018-2024) & (US$ Million)
Table 107. Middle East, Africa and Latin America Polypeptide Drug Revenue by Country (2024-2029) & (US$ Million)
Table 108. Middle East, Africa and Latin America Polypeptide Drug Sales by Country (2018-2024) & (MT)
Table 109. Middle East, Africa and Latin America Polypeptide Drug Sales by Country (2024-2029) & (MT)
Table 110. Novartis Company Information
Table 111. Novartis Description and Major Businesses
Table 112. Novartis Polypeptide Drug Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 113. Novartis Polypeptide Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Novartis Recent Developments
Table 115. Merck Serono Company Information
Table 116. Merck Serono Description and Major Businesses
Table 117. Merck Serono Polypeptide Drug Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 118. Merck Serono Polypeptide Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Merck Serono Recent Developments
Table 120. Ferring Pharmaceuticals Company Information
Table 121. Ferring Pharmaceuticals Description and Major Businesses
Table 122. Ferring Pharmaceuticals Polypeptide Drug Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 123. Ferring Pharmaceuticals Polypeptide Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Ferring Pharmaceuticals Recent Developments
Table 125. Ipsen PHarma Biotech Company Information
Table 126. Ipsen PHarma Biotech Description and Major Businesses
Table 127. Ipsen PHarma Biotech Polypeptide Drug Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 128. Ipsen PHarma Biotech Polypeptide Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Ipsen PHarma Biotech Recent Developments
Table 130. Lilly Company Information
Table 131. Lilly Description and Major Businesses
Table 132. Lilly Polypeptide Drug Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 133. Lilly Polypeptide Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Lilly Recent Developments
Table 135. Asahi Kasei Company Information
Table 136. Asahi Kasei Description and Major Businesses
Table 137. Asahi Kasei Polypeptide Drug Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 138. Asahi Kasei Polypeptide Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Asahi Kasei Recent Developments
Table 140. AstraZeneca Company Information
Table 141. AstraZeneca Description and Major Businesses
Table 142. AstraZeneca Polypeptide Drug Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 143. AstraZeneca Polypeptide Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. AstraZeneca Recent Developments
Table 145. SciClone Pharmaceuticals Company Information
Table 146. SciClone Pharmaceuticals Description and Major Businesses
Table 147. SciClone Pharmaceuticals Polypeptide Drug Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 148. SciClone Pharmaceuticals Polypeptide Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. SciClone Pharmaceuticals Recent Developments
Table 150. Takeda Company Information
Table 151. Takeda Description and Major Businesses
Table 152. Takeda Polypeptide Drug Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 153. Takeda Polypeptide Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. Takeda Recent Developments
Table 155. Roche Company Information
Table 156. Roche Description and Major Businesses
Table 157. Roche Polypeptide Drug Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 158. Roche Polypeptide Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 159. Roche Recent Developments
Table 160. Sanofi Company Information
Table 161. Sanofi Description and Major Businesses
Table 162. Sanofi Polypeptide Drug Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 163. Sanofi Polypeptide Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 164. Sanofi Recent Developments
Table 165. Key Raw Materials Lists
Table 166. Raw Materials Key Suppliers Lists
Table 167. Polypeptide Drug Distributors List
Table 168. Polypeptide Drug Customers List
Table 169. Polypeptide Drug Market Trends
Table 170. Polypeptide Drug Market Drivers
Table 171. Polypeptide Drug Market Challenges
Table 172. Polypeptide Drug Market Restraints
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
List of Figures
Figure 1. Polypeptide Drug Product Picture
Figure 2. Global Polypeptide Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Polypeptide Drug Market Share by Type in 2022 & 2029
Figure 4. Injection Product Picture
Figure 5. Nasal Administration Product Picture
Figure 6. Lung Administration Product Picture
Figure 7. Oral Administration Product Picture
Figure 8. Transdermal Administration Product Picture
Figure 9. Global Polypeptide Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 10. Global Polypeptide Drug Market Share by Application in 2022 & 2029
Figure 11. Immunity Regulating Medicine (Allergy Infection and Immune)
Figure 12. Digestive System Drugs (Gastrointestinal Type)
Figure 13. Bone and Connective Tissue Types (Thyroid hormones Drug)
Figure 14. Gynecologic or Obstetric Drug
Figure 15. Tumor Drug
Figure 16. Urinary System Drug
Figure 17. Metabolic Drug (Insulin and Other Hypoglycemic Agents)
Figure 18. Polypeptide Drug Report Years Considered
Figure 19. Global Polypeptide Drug Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 20. Global Polypeptide Drug Revenue 2018-2029 (US$ Million)
Figure 21. Global Polypeptide Drug Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 22. Global Polypeptide Drug Revenue Market Share by Region (2018-2029)
Figure 23. Global Polypeptide Drug Sales 2018-2029 ((MT)
Figure 24. Global Polypeptide Drug Sales Market Share by Region (2018-2029)
Figure 25. US & Canada Polypeptide Drug Sales YoY (2018-2029) & (MT)
Figure 26. US & Canada Polypeptide Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 27. Europe Polypeptide Drug Sales YoY (2018-2029) & (MT)
Figure 28. Europe Polypeptide Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 29. China Polypeptide Drug Sales YoY (2018-2029) & (MT)
Figure 30. China Polypeptide Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 31. Asia (excluding China) Polypeptide Drug Sales YoY (2018-2029) & (MT)
Figure 32. Asia (excluding China) Polypeptide Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 33. Middle East, Africa and Latin America Polypeptide Drug Sales YoY (2018-2029) & (MT)
Figure 34. Middle East, Africa and Latin America Polypeptide Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 35. The Polypeptide Drug Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 36. The Top 5 and 10 Largest Manufacturers of Polypeptide Drug in the World: Market Share by Polypeptide Drug Revenue in 2022
Figure 37. Global Polypeptide Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 38. Global Polypeptide Drug Sales Market Share by Type (2018-2029)
Figure 39. Global Polypeptide Drug Revenue Market Share by Type (2018-2029)
Figure 40. Global Polypeptide Drug Sales Market Share by Application (2018-2029)
Figure 41. Global Polypeptide Drug Revenue Market Share by Application (2018-2029)
Figure 42. US & Canada Polypeptide Drug Sales Market Share by Type (2018-2029)
Figure 43. US & Canada Polypeptide Drug Revenue Market Share by Type (2018-2029)
Figure 44. US & Canada Polypeptide Drug Sales Market Share by Application (2018-2029)
Figure 45. US & Canada Polypeptide Drug Revenue Market Share by Application (2018-2029)
Figure 46. US & Canada Polypeptide Drug Revenue Share by Country (2018-2029)
Figure 47. US & Canada Polypeptide Drug Sales Share by Country (2018-2029)
Figure 48. U.S. Polypeptide Drug Revenue (2018-2029) & (US$ Million)
Figure 49. Canada Polypeptide Drug Revenue (2018-2029) & (US$ Million)
Figure 50. Europe Polypeptide Drug Sales Market Share by Type (2018-2029)
Figure 51. Europe Polypeptide Drug Revenue Market Share by Type (2018-2029)
Figure 52. Europe Polypeptide Drug Sales Market Share by Application (2018-2029)
Figure 53. Europe Polypeptide Drug Revenue Market Share by Application (2018-2029)
Figure 54. Europe Polypeptide Drug Revenue Share by Country (2018-2029)
Figure 55. Europe Polypeptide Drug Sales Share by Country (2018-2029)
Figure 56. Germany Polypeptide Drug Revenue (2018-2029) & (US$ Million)
Figure 57. France Polypeptide Drug Revenue (2018-2029) & (US$ Million)
Figure 58. U.K. Polypeptide Drug Revenue (2018-2029) & (US$ Million)
Figure 59. Italy Polypeptide Drug Revenue (2018-2029) & (US$ Million)
Figure 60. Russia Polypeptide Drug Revenue (2018-2029) & (US$ Million)
Figure 61. China Polypeptide Drug Sales Market Share by Type (2018-2029)
Figure 62. China Polypeptide Drug Revenue Market Share by Type (2018-2029)
Figure 63. China Polypeptide Drug Sales Market Share by Application (2018-2029)
Figure 64. China Polypeptide Drug Revenue Market Share by Application (2018-2029)
Figure 65. Asia Polypeptide Drug Sales Market Share by Type (2018-2029)
Figure 66. Asia Polypeptide Drug Revenue Market Share by Type (2018-2029)
Figure 67. Asia Polypeptide Drug Sales Market Share by Application (2018-2029)
Figure 68. Asia Polypeptide Drug Revenue Market Share by Application (2018-2029)
Figure 69. Asia Polypeptide Drug Revenue Share by Region (2018-2029)
Figure 70. Asia Polypeptide Drug Sales Share by Region (2018-2029)
Figure 71. Japan Polypeptide Drug Revenue (2018-2029) & (US$ Million)
Figure 72. South Korea Polypeptide Drug Revenue (2018-2029) & (US$ Million)
Figure 73. China Taiwan Polypeptide Drug Revenue (2018-2029) & (US$ Million)
Figure 74. Southeast Asia Polypeptide Drug Revenue (2018-2029) & (US$ Million)
Figure 75. India Polypeptide Drug Revenue (2018-2029) & (US$ Million)
Figure 76. Middle East, Africa and Latin America Polypeptide Drug Sales Market Share by Type (2018-2029)
Figure 77. Middle East, Africa and Latin America Polypeptide Drug Revenue Market Share by Type (2018-2029)
Figure 78. Middle East, Africa and Latin America Polypeptide Drug Sales Market Share by Application (2018-2029)
Figure 79. Middle East, Africa and Latin America Polypeptide Drug Revenue Market Share by Application (2018-2029)
Figure 80. Middle East, Africa and Latin America Polypeptide Drug Revenue Share by Country (2018-2029)
Figure 81. Middle East, Africa and Latin America Polypeptide Drug Sales Share by Country (2018-2029)
Figure 82. Brazil Polypeptide Drug Revenue (2018-2029) & (US$ Million)
Figure 83. Mexico Polypeptide Drug Revenue (2018-2029) & (US$ Million)
Figure 84. Turkey Polypeptide Drug Revenue (2018-2029) & (US$ Million)
Figure 85. Israel Polypeptide Drug Revenue (2018-2029) & (US$ Million)
Figure 86. GCC Countries Polypeptide Drug Revenue (2018-2029) & (US$ Million)
Figure 87. Polypeptide Drug Value Chain
Figure 88. Polypeptide Drug Production Process
Figure 89. Channels of Distribution
Figure 90. Distributors Profiles
Figure 91. Bottom-up and Top-down Approaches for This Report
Figure 92. Data Triangulation
Figure 93. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries